Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05342571 · ClinicalTrials.gov registry record · NA
A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05342571 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 30 participants.
The verdict
NCT05342571, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This phase IIb trial studies the effect of a biobehavioral/cognitive (ABC) treatment on stress, depression, and anxiety in patients with stage IV lung cancer. Advanced lung cancer and stress or depression are associated with increased inflammation and decreased immunity. ABC is a combination of biobehavioral intervention, which studies the interaction between behavioral and biological processes, and cognitive therapy for the treatment for anxiety and depressive disorders. Giving ABC during lung cancer treatment may reduce stress, depression, and anxiety, and improve patients' quality of life and health.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Survey Administration
- OTHER Electronic Health Record Review
- OTHER Informational Intervention
- OTHER Behavioral, Psychological or Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05342571
The ClinicalTrials.gov registry entry for NCT05342571 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT05342571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05342571 about?
NCT05342571 is a clinical study titled "A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung Cancer". This phase IIb trial studies the effect of a biobehavioral/cognitive (ABC) treatment on stress, depression, and anxiety in patients with stage IV lung cancer. Advanced lung cancer and stress or depression are associated with increased inflammation and decreased immunity. ABC is a combination of biob...
What is the current status of trial NCT05342571?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-06-01. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT05342571?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Survey Administration (OTHER), Electronic Health Record Review (OTHER), Informational Intervention (OTHER), Behavioral, Psychological or Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT05342571?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.